194 related articles for article (PubMed ID: 37286851)
1. [Sinonasal neoplasms: Update from the WHO 2022].
Agaimy A
Pathologie (Heidelb); 2023 Jul; 44(4):233-239. PubMed ID: 37286851
[TBL] [Abstract][Full Text] [Related]
2. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview.
Agaimy A
Head Neck Pathol; 2022 Mar; 16(1):168-178. PubMed ID: 35307773
[TBL] [Abstract][Full Text] [Related]
3. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
[TBL] [Abstract][Full Text] [Related]
4. SMARCA4-deficient Sinonasal Carcinoma.
Agaimy A; Weichert W
Head Neck Pathol; 2017 Dec; 11(4):541-545. PubMed ID: 28176137
[TBL] [Abstract][Full Text] [Related]
5. SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
[TBL] [Abstract][Full Text] [Related]
6. SWI/SNF-deficient Sinonasal Carcinomas.
Agaimy A
Adv Anat Pathol; 2023 Mar; 30(2):95-103. PubMed ID: 36580412
[TBL] [Abstract][Full Text] [Related]
7. SWI/SNF-deficient head and neck neoplasms: An overview.
Agaimy A; Bishop JA
Semin Diagn Pathol; 2021 May; 38(3):175-182. PubMed ID: 33663878
[TBL] [Abstract][Full Text] [Related]
8. High-Grade Sinonasal Carcinoma: Classification Through Molecular Profiling.
Guilmette J; Sadow PM
Arch Pathol Lab Med; 2019 Nov; 143(11):1416-1419. PubMed ID: 30779592
[TBL] [Abstract][Full Text] [Related]
9. INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies.
Shaverdashvili K; Azimi-Nekoo E; Cohen P; Akbar N; Ow TJ; Halmos B; Castellucci E
Oncologist; 2020 Sep; 25(9):738-744. PubMed ID: 32337786
[TBL] [Abstract][Full Text] [Related]
10. Sinonasal Undifferentiated Carcinoma (SNUC): From an Entity to Morphologic Pattern and Back Again-A Historical Perspective.
Agaimy A; Franchi A; Lund VJ; Skálová A; Bishop JA; Triantafyllou A; Andreasen S; Gnepp DR; Hellquist H; Thompson LDR; Rinaldo A; Ferlito A
Adv Anat Pathol; 2020 Mar; 27(2):51-60. PubMed ID: 31876536
[TBL] [Abstract][Full Text] [Related]
11. SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract.
Bishop JA; Antonescu CR; Westra WH
Am J Surg Pathol; 2014 Sep; 38(9):1282-9. PubMed ID: 25007146
[TBL] [Abstract][Full Text] [Related]
12. New tumor entities in the 4th edition of the World Health Organization classification of head and neck tumors: Nasal cavity, paranasal sinuses and skull base.
Thompson LDR; Franchi A
Virchows Arch; 2018 Mar; 472(3):315-330. PubMed ID: 28444451
[TBL] [Abstract][Full Text] [Related]
13. Differentiated Papillary NUT Carcinoma: An Unexpected, Deceptively Bland Presentation of a Sinonasal Carcinoma.
Wartenberg M; Hool SL; Marrazzini A; Giger R; Rupp NJ
Head Neck Pathol; 2023 Sep; 17(3):803-807. PubMed ID: 37118352
[TBL] [Abstract][Full Text] [Related]
14. SMARCA4/BRG1-Deficient Sinonasal Carcinoma.
Kakkar A; Ashraf SF; Rathor A; Adhya AK; Mani S; Sikka K; Jain D
Arch Pathol Lab Med; 2022 Sep; 146(9):1122-1130. PubMed ID: 34871352
[TBL] [Abstract][Full Text] [Related]
15. SMARCB1 (INI1)-Deficient Sinonasal Carcinoma with Yolk Sac differentiation Showing Co-loss of SMARCA4 Immunostaining - A Case Report and Literature Review.
Ng JKM; Chan JYK; Li JJX; Tang K; Yeung DCM; Chan ABW
Head Neck Pathol; 2022 Sep; 16(3):934-941. PubMed ID: 35257325
[TBL] [Abstract][Full Text] [Related]
16. [Sinonasal tumors : News from the WHO with special reference to mesenchymal entities].
Agaimy A; Haller F; Hartmann A
Pathologe; 2018 Feb; 39(1):18-26. PubMed ID: 29396607
[TBL] [Abstract][Full Text] [Related]
17. DEK-AFF2 Carcinoma of the Sinonasal Region and Skull Base: Detailed Clinicopathologic Characterization of a Distinctive Entity.
Rooper LM; Agaimy A; Dickson BC; Dueber JC; Eberhart CG; Gagan J; Hartmann A; Khararjian A; London NR; MacMillan CM; Palsgrove DN; Nix JS; Sandison A; Stoehr R; Truong T; Weinreb I; Bishop JA
Am J Surg Pathol; 2021 Dec; 45(12):1682-1693. PubMed ID: 34049316
[TBL] [Abstract][Full Text] [Related]
18. The contemporary management of cancers of the sinonasal tract in adults.
Thawani R; Kim MS; Arastu A; Feng Z; West MT; Taflin NF; Thein KZ; Li R; Geltzeiler M; Lee N; Fuller CD; Grandis JR; Floudas CS; Heinrich MC; Hanna E; Chandra RA
CA Cancer J Clin; 2023 Jan; 73(1):72-112. PubMed ID: 35916666
[TBL] [Abstract][Full Text] [Related]
19. DEK-AFF2 fusion-associated papillary squamous cell carcinoma of the sinonasal tract: clinicopathologic characterization of seven cases with deceptively bland morphology.
Kuo YJ; Lewis JS; Zhai C; Chen YA; Chernock RD; Hsieh MS; Lan MY; Lee CK; Weinreb I; Hang JF
Mod Pathol; 2021 Oct; 34(10):1820-1830. PubMed ID: 34108636
[TBL] [Abstract][Full Text] [Related]
20. Nuclear expression of AFF2 C-terminus is a sensitive and specific ancillary marker for DEK::AFF2 carcinoma of the sinonasal tract.
Kuo YJ; Lewis JS; Truong T; Yeh YC; Chernock RD; Zhai C; Chen YA; Hongo T; Lee CK; Shi Q; Velez Torres JM; Geromes AB; Chu YH; Hsieh MS; Yamamoto H; Weinreb I; Hang JF
Mod Pathol; 2022 Nov; 35(11):1587-1595. PubMed ID: 35701667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]